Sentinel Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
WG
Sentinel Trust's PFE Position: Q2 2026 in Review
Sentinel Trust reduced its Pfizer (PFE) stake by 4.2% in Q2 2026, selling an estimated $11.8K and leaving 10,143 shares worth $244K. The position accounts for 0.02% of the portfolio, ranked #128.
Sentinel Trust first reported a position in PFE in Q2 2013 and has held it in 23 quarters since. The position peaked at $587K in Q1 2014. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Sentinel Trust held 10,143 shares of Pfizer worth $244K as of Q2 2026.
- Sentinel Trust sold 450 Pfizer shares in Q2 2026, an estimated $11.8K.
- Pfizer made up 0.02% of Sentinel Trust's portfolio in Q2 2026, its #128 holding.
- Sentinel Trust first reported a position in Pfizer in Q2 2013 and has held it in 23 quarters since.
- Sentinel Trust's Pfizer position peaked at $587K in Q1 2014.
- 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Sentinel Trust's 13F filing for Q2 2026, filed 13 Jul 2026.